Jo Seunghyun, Kim Eunsom, Kwak Areum, Lee Jungmin, Hong Jaewoo, Lee Jongho, Youn Sulah, Bae Suyoung, Kim Busun, Ryoo Soyoon, Kang Tae-Bong, Her Erk, Choi Dong-Ki, Kim Yong-Sung, Lee Youngmin, Jhun Hyunjhung, Kim Soohyun
Laboratory of Cytokine Immunology, Department of Biomedical Science and Technology, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 143-701, Republic of Korea; College of Veterinary Medicine, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 143-701, Republic of Korea.
Laboratory of Cytokine Immunology, Department of Biomedical Science and Technology, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 143-701, Republic of Korea.
Cytokine. 2016 Jul;83:33-40. doi: 10.1016/j.cyto.2016.03.013. Epub 2016 Mar 28.
Interleukin-33 (IL-33) receptors are composed of ST2 (also known as IL-1R4), a ligand binding chain, and IL-1 receptor accessory protein (IL-1RAcP, also known as IL-1R3), a signal transducing chain. IL-1R3 is a common receptor for IL-1α, and IL-1β, IL-33, and three IL-36 isoforms. A549 human lung epithelial cells are highly sensitive to IL-1α and IL-1β but not respond to IL-33. The lack of responsiveness to IL-33 is due to ST2 expression. ST2 was stably transfected into A549 cells to reconstitute its activity. RT-PCR and FACS analysis confirmed ST2 expression on the cell surface of A549/ST2 cells. Upon IL-33 stimulation, A549/ST2 cells induced IL-8 and IL-6 production in a dose dependent manner while A549/mock cells remained unresponsive. There was no difference in IL-1α and IL-1β activity in A549/ST2 cells compared to A549/mock cells despite the fact that IL-33 shares IL-1R3 with IL-1α/β. IL-33 activated inflammatory signaling molecules in a time- and dose-dependent manner. Anti-ST2 antibody and soluble recombinant ST2-Fc abolished IL-33-induced IL-6 and IL-8 production in A549/ST2 cells but the IL-1 receptor antagonist failed to block IL-33-induced cytokines. This result demonstrates for the first time the reconstitution of ST2 in A549 human lung epithelial cell line and verified its function in IL-33-mediated cytokine production and signal transduction.
白细胞介素-33(IL-33)受体由配体结合链ST2(也称为IL-1R4)和信号转导链白细胞介素-1受体辅助蛋白(IL-1RAcP,也称为IL-1R3)组成。IL-1R3是IL-1α、IL-1β、IL-33和三种IL-36亚型的共同受体。A549人肺上皮细胞对IL-1α和IL-1β高度敏感,但对IL-33无反应。对IL-33无反应是由于ST2的表达。将ST2稳定转染到A549细胞中以恢复其活性。逆转录聚合酶链反应(RT-PCR)和荧光激活细胞分选(FACS)分析证实了A549/ST2细胞表面ST2的表达。在IL-33刺激下,A549/ST2细胞以剂量依赖性方式诱导IL-8和IL-6的产生,而A549/对照细胞仍然无反应。尽管IL-33与IL-1α/β共享IL-1R3,但与A549/对照细胞相比,A549/ST2细胞中IL-1α和IL-1β的活性没有差异。IL-33以时间和剂量依赖性方式激活炎症信号分子。抗ST2抗体和可溶性重组ST2-Fc消除了IL-33诱导的A549/ST2细胞中IL-6和IL-8的产生,但白细胞介素-1受体拮抗剂未能阻断IL-33诱导的细胞因子。该结果首次证明了在A549人肺上皮细胞系中ST2的重建,并验证了其在IL-33介导的细胞因子产生和信号转导中的功能。